Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 10.2 Good

Insilico Medicine AI-Discovered Drug Enters Phase III Trials

This demonstrates AI's potential to accelerate drug discovery and bring novel therapies to clinical stages, advancing medical innovation.

This demonstrates AI’s potential to accelerate drug discovery and bring novel therapies to clinical stages, advancing medical innovation.

Auto-scored: A major beneficial development in AI-driven medicine with no associated risks.